was briefly on WADA watch list TB-500 Not approved Prohibited Research use only Thymosin Alpha-1 Not approved in US Permitted Approved in some countries (Italy, China) Ipamorelin Not approved Prohibited Research use only Key point: None of these compounds are FDA-approved for human therapeutic use in the United States
Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC 157 in rat and mouse
The regulatory environment may also evolve
There is also evidence that it increases noradrenaline levels in the brain, which helps with cognitive function and mood, energizing the use to do more
TB-500 single-compound vial for protocols that require TB-500 alone
Some users report mild side effects, including: Temporary redness at the injection site Slight fatigue Digestive discomfort with capsules These effects are usually minimal compared to other performance-enhancing compounds